Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
FLXN

Flexion

$24.96

-1.6 (-6.02%)

08:46
06/28/18
06/28
08:46
06/28/18
08:46
Initiation
Flexion initiated  »

Benchmark says Zilretta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$24.96

-1.6 (-6.02%)

06:24
06/28/18
06/28
06:24
06/28/18
06:24
Initiation
Flexion initiated at Benchmark »

Flexion initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$28.40

1 (3.65%)

, ANIK

Anika Therapeutics

$30.23

-15.765 (-34.28%)

10:45
06/20/18
06/20
10:45
06/20/18
10:45
Hot Stocks
Flexion seen benefiting from Anika Therapeutics' failed Cingal study »

Shares of Flexion (FLXN)…

FLXN

Flexion

$28.40

1 (3.65%)

ANIK

Anika Therapeutics

$30.23

-15.765 (-34.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

FLXN

Flexion

$27.40

0.63 (2.35%)

, ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

19:21
06/19/18
06/19
19:21
06/19/18
19:21
Recommendations
Flexion, Anika Therapeutics analyst commentary at Wells Fargo »

Flexion to benefit from…

FLXN

Flexion

$27.40

0.63 (2.35%)

ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

Over a month ago
FLXN

Flexion

$25.67

-0.25 (-0.96%)

16:10
05/08/18
05/08
16:10
05/08/18
16:10
Earnings
Flexion reports Q1 EPS ($1.10), consensus ($1.33) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 09

    May

  • 30

    May

FLXN

Flexion

$26.00

0.75 (2.97%)

07:31
05/07/18
05/07
07:31
05/07/18
07:31
Hot Stocks
Flexion names David Arkowitz CFO »

Flexion Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 09

    May

  • 30

    May

FLXN

Flexion

$26.31

1.06 (4.20%)

11:39
05/04/18
05/04
11:39
05/04/18
11:39
Recommendations
Flexion analyst commentary at Wells Fargo »

Flexion J code progress…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 09

    May

  • 30

    May

FLXN

Flexion

$25.25

-0.41 (-1.60%)

07:34
05/04/18
05/04
07:34
05/04/18
07:34
Hot Stocks
Flexion announces Zilretta recommended for unique J code by CMS »

Flexion Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 09

    May

  • 30

    May

FLXN

Flexion

$25.88

-0.72 (-2.71%)

10:27
04/29/18
04/29
10:27
04/29/18
10:27
Hot Stocks
Flexion announces presentation of positive FX201 data »

Flexion Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$26.75

0.15 (0.56%)

10:25
04/27/18
04/27
10:25
04/27/18
10:25
Conference/Events
Flexion to participate in a conference call with Wells Fargo »

Wells Fargo Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.